NO307985B1 - Farmasøytiske preparater samt anvendelse av syklopeptider ved fremstilling av medikamenter - Google Patents

Farmasøytiske preparater samt anvendelse av syklopeptider ved fremstilling av medikamenter

Info

Publication number: NO307985B1
Authority: NO; Norway
Prior art keywords: gly; cyclo; phe; asp; arg
Prior art date: 1992-07-06

Application number

NO932439A

Other languages

English (en)

Norwegian (no)

Other versions

NO932439L (no

NO932439D0 (no

Inventor

Alfred Jonczyk

Guenter Hoelzemann

Brunhilde Felding-Habermann

Guido Melzer

Beate Diefenbach

David A Cheresh

Horst Kessler

Marion Gurrath

Gerhard Mueller

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-06

Filing date

1993-07-05

Publication date

2000-07-03

1993-07-05 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1993-07-05 Publication of NO932439D0 publication Critical patent/NO932439D0/no

1994-01-07 Publication of NO932439L publication Critical patent/NO932439L/no

2000-07-03 Publication of NO307985B1 publication Critical patent/NO307985B1/no

Links

108010069514 Cyclic Peptides Proteins 0.000 title abstract 2
102000001189 Cyclic Peptides Human genes 0.000 title abstract 2
239000003814 drug Substances 0.000 title 2
238000004519 manufacturing process Methods 0.000 title 1
YYQUWEHEBOMRPH-NYUBLWNDSA-N 2-[(2s,5r,8s,11s)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H]1CC1=CC=CC=C1 YYQUWEHEBOMRPH-NYUBLWNDSA-N 0.000 abstract 1
OJOVBVONXDWCFW-CBHOWOPOSA-N 2-[(2s,5r,8s,11s,14s)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C(C)C)NC(=O)[C@H]1CC1=CC=CC=C1 OJOVBVONXDWCFW-CBHOWOPOSA-N 0.000 abstract 1
230000021164 cell adhesion Effects 0.000 abstract 1
108010083321 cyclic(arginyl-alanyl-aspartyl-phenylalanyl-valyl) Proteins 0.000 abstract 1
108010028542 cyclic(arginyl-glycyl-aspartyl-phenylalanyl-leucyl-glycyl) Proteins 0.000 abstract 1
108010050963 cyclo(arginyl-glycyl-aspartyl-phenylalanyl-valyl) Proteins 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Physical Education & Sports Medicine (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Rheumatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO932439A 1992-07-06 1993-07-05 Farmasøytiske preparater samt anvendelse av syklopeptider ved fremstilling av medikamenter NO307985B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90936792A	1992-07-06	1992-07-06
US2202493A	1993-02-24	1993-02-24

Publications (3)

Publication Number	Publication Date
NO932439D0 NO932439D0 (no)	1993-07-05
NO932439L NO932439L (no)	1994-01-07
NO307985B1 true NO307985B1 (no)	2000-07-03

Family

ID=26695386

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO932439A NO307985B1 (no)	1992-07-06	1993-07-05	Farmasøytiske preparater samt anvendelse av syklopeptider ved fremstilling av medikamenter

Country Status (19)

Country	Link
US (1)	US5866540A (sk)
EP (1)	EP0578083B1 (sk)
JP (2)	JP3803392B2 (sk)
KR (1)	KR100261898B1 (sk)
CN (1)	CN1065438C (sk)
AT (1)	ATE178491T1 (sk)
AU (2)	AU675946B2 (sk)
CA (1)	CA2099541C (sk)
CZ (1)	CZ283744B6 (sk)
DE (1)	DE69324305T2 (sk)
DK (1)	DK0578083T3 (sk)
ES (1)	ES2131542T3 (sk)
HU (1)	HU212572B (sk)
MX (1)	MX9304035A (sk)
NO (1)	NO307985B1 (sk)
PL (1)	PL173785B1 (sk)
SK (1)	SK282024B6 (sk)
TW (1)	TW393319B (sk)
UA (1)	UA43823C2 (sk)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5654267A (en) *	1988-12-20	1997-08-05	La Jolla Cancer Research Center	Cooperative combinations of ligands contained within a matrix
DE4310643A1 (de)	1993-04-01	1994-10-06	Merck Patent Gmbh	Cyclische Adhäsionsinhibitoren
US5753230A (en) *	1994-03-18	1998-05-19	The Scripps Research Institute	Methods and compositions useful for inhibition of angiogenesis
US5770565A (en) *	1994-04-13	1998-06-23	La Jolla Cancer Research Center	Peptides for reducing or inhibiting bone resorption
DE4415310A1 (de) *	1994-04-30	1995-11-02	Merck Patent Gmbh	Cyclopeptide
US6056958A (en) *	1994-12-09	2000-05-02	Dupont Pharmaceuticals	Method of treatment of arterial and venous thromboembolic disorders
US6492332B1 (en) *	1995-12-12	2002-12-10	Omeros Corporation	Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
DE4444260A1 (de) *	1994-12-13	1996-06-20	Hoechst Ag	Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung
US5767071A (en) *	1995-06-07	1998-06-16	Ixsys Incorporated	Sevenmer cyclic peptide inhibitors of diseases involving αv β3
US5780426A (en) *	1995-06-07	1998-07-14	Ixsys, Incorporated	Fivemer cyclic peptide inhibitors of diseases involving αv β3
US7053041B1 (en) *	1996-05-31	2006-05-30	The Scripps Research Institute	Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
WO1997006791A1 (en) *	1995-08-14	1997-02-27	The Scripps Research Institute	METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
US5817750A (en) *	1995-08-28	1998-10-06	La Jolla Cancer Research Foundation	Structural mimics of RGD-binding sites
US6080719A (en) *	1996-02-23	2000-06-27	Hoechst Aktiengesellschaft	Cyclohexapeptides and their mixtures, a process for preparing them, and their use
DE19613933A1 (de) *	1996-04-06	1997-10-09	Merck Patent Gmbh	Cyclische Adhäsionsinhibitoren
AU738782B2 (en)	1996-05-31	2001-09-27	Scripps Research Institute, The	Methods and compositions useful for inhibition of alphavbeta5 mediated angiogenesis
US6245809B1 (en)	1996-12-09	2001-06-12	Cor Therapeutics Inc.	Integrin antagonists
DE19728524A1 (de) *	1997-07-04	1999-01-07	Merck Patent Gmbh	Cyclische Azapeptide
DE19736772A1 (de) *	1997-08-23	1999-02-25	Merck Patent Gmbh	Cyclopeptidderivate
US6852318B1 (en)	1998-05-08	2005-02-08	The Regents Of The University Of California	Methods for detecting and inhibiting angiogenesis
WO1999065944A1 (en) *	1998-06-15	1999-12-23	Ixsys Incorporated	PEPTIDE INHIBITORS OF αVβ3 AND αVβ¿5?
CA2288680A1 (en) *	1998-11-12	2000-05-12	Jcr Pharmaceuticals Co., Ltd.	Modulation of cell proliferative disorders by cyclic rgd
UA71608C2 (en) *	1999-03-11	2004-12-15	Merck Patent Gmbh	A method for producing the cyclic pentapeptide
WO2001077145A2 (en)	2000-04-12	2001-10-18	Amersham Health As	Integrin binding peptide derivatives
NO20004795D0 (no)	2000-09-26	2000-09-26	Nycomed Imaging As	Peptidbaserte forbindelser
US20030133972A1 (en) *	2000-10-11	2003-07-17	Targesome, Inc.	Targeted multivalent macromolecules
US20030129223A1 (en) *	2000-10-11	2003-07-10	Targesome, Inc.	Targeted multivalent macromolecules
US20030082103A1 (en) *	2000-10-11	2003-05-01	Targesome, Inc.	Targeted therapeutic lipid constructs having cell surface targets
JP5054274B2 (ja)	2000-11-01	2012-10-24	メルクパテントゲゼルシャフトミットベシュレンクテルハフツング	眼の疾患を治療するための方法および組成物
UA75898C2 (en) *	2000-11-14	2006-06-15	Merck Patent Gmbh	Method for prophylaxis and treatment of eye diseases using antagonist of integrin receptors
JP4510444B2 (ja)	2001-07-10	2010-07-21	ジーイー・ヘルスケア・アクスイェ・セルスカプ	ペプチドベースの化合物
US7597907B2 (en) *	2004-11-05	2009-10-06	Trustees Of The University Of Pennsylvania	Antioxidant polymer nanocarriers for use in preventing oxidative injury
US7605056B2 (en)	2005-05-31	2009-10-20	Semiconductor Energy Laboratory Co., Ltd.	Method of manufacturing a semiconductor device including separation by physical force
US7927629B2 (en) *	2007-10-27	2011-04-19	The Trustees Of The University Of Pennsylvania	Method and compositions for polymer nanocarriers containing therapeutic molecules
US8568786B2 (en) *	2007-10-27	2013-10-29	The Trustees Of The Universtiy Of Pennsylvania	Method and compositions for polymer nanocarriers containing therapeutic molecules
JP5647972B2 (ja) *	2008-04-08	2015-01-07	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	環状ペプチドを含む組成物および使用方法
JP2012513589A (ja)	2008-12-23	2012-06-14	ジーイー・ヘルスケア・リミテッド	骨髄イメージング剤としての９９ｍＴｃ−ペプチド系化合物の応用
WO2012007137A1 (en) *	2010-07-16	2012-01-19	Merck Patent Gmbh	Peptide for use in the treatment of breast cancer and/or bone metastases
AU2013312981B2 (en) *	2012-09-06	2017-06-22	Mcpharma Biotech Inc.	Treatment of diarrhea and post-weaning diarrhea with resistant potato starch
WO2018200368A1 (en) *	2017-04-24	2018-11-01	The Regents Of The University Of California	Cell permeable cyclic peptide scaffolds
EP3684785B1 (en) *	2017-09-19	2024-10-02	Technische Universität München	N-methylated cyclic peptides and their prodrugs
KR102213196B1 (ko) *	2018-05-08	2021-02-05	주식회사 메디폴리머	클릭화학 반응을 통해 필러 또는 약물전달체로 사용하기 위한 주사제형 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2945680B2 (ja) *	1988-09-09	1999-09-06	旭硝子株式会社	ペプチド誘導体およびその用途
EP0410537A1 (en) *	1989-07-28	1991-01-30	Merck & Co. Inc.	Fibrinogen receptor antagonists
JPH05509294A (ja) *	1990-04-06	1993-12-22	ラ　ホヤ　キャンサー　リサーチ　ファウンデーション	血栓症治療のための方法および組成物
US5192746A (en) *	1990-07-09	1993-03-09	Tanabe Seiyaku Co., Ltd.	Cyclic cell adhesion modulation compounds

1993
- 1993-06-18 UA UA93002630A patent/UA43823C2/uk unknown
- 1993-06-24 JP JP15346293A patent/JP3803392B2/ja not_active Expired - Lifetime
- 1993-06-26 DE DE69324305T patent/DE69324305T2/de not_active Expired - Lifetime
- 1993-06-26 DK DK93110232T patent/DK0578083T3/da active
- 1993-06-26 EP EP93110232A patent/EP0578083B1/en not_active Expired - Lifetime
- 1993-06-26 AT AT93110232T patent/ATE178491T1/de active
- 1993-06-26 ES ES93110232T patent/ES2131542T3/es not_active Expired - Lifetime
- 1993-06-30 CZ CZ931315A patent/CZ283744B6/cs not_active IP Right Cessation
- 1993-07-02 CA CA002099541A patent/CA2099541C/en not_active Expired - Lifetime
- 1993-07-05 PL PL93299559A patent/PL173785B1/pl unknown
- 1993-07-05 HU HU9301950A patent/HU212572B/hu unknown
- 1993-07-05 MX MX9304035A patent/MX9304035A/es unknown
- 1993-07-05 KR KR1019930012550A patent/KR100261898B1/ko not_active IP Right Cessation
- 1993-07-05 NO NO932439A patent/NO307985B1/no not_active IP Right Cessation
- 1993-07-06 SK SK706-93A patent/SK282024B6/sk not_active IP Right Cessation
- 1993-07-06 AU AU41796/93A patent/AU675946B2/en not_active Expired
- 1993-07-06 CN CN93108015A patent/CN1065438C/zh not_active Expired - Lifetime
- 1993-08-18 TW TW082106697A patent/TW393319B/zh not_active IP Right Cessation
1995
- 1995-01-04 US US08/368,760 patent/US5866540A/en not_active Expired - Lifetime
1997
- 1997-02-13 AU AU12687/97A patent/AU1268797A/en not_active Abandoned
2004
- 2004-05-06 JP JP2004137652A patent/JP4192114B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PL299559A1 (en)	1994-03-21
US5866540A (en)	1999-02-02
HU9301950D0 (en)	1993-09-28
NO932439L (no)	1994-01-07
CZ131593A3 (en)	1994-02-16
UA43823C2 (uk)	2002-01-15
MX9304035A (es)	1994-04-29
CA2099541C (en)	2009-08-25
AU4179693A (en)	1994-01-13
EP0578083A2 (en)	1994-01-12
KR940001900A (ko)	1994-02-16
ES2131542T3 (es)	1999-08-01
TW393319B (en)	2000-06-11
SK70693A3 (en)	1994-02-02
JP2004224803A (ja)	2004-08-12
PL173785B1 (pl)	1998-04-30
KR100261898B1 (ko)	2000-07-15
SK282024B6 (sk)	2001-10-08
EP0578083A3 (sk)	1994-08-03
HU212572B (en)	1996-08-29
DE69324305T2 (de)	1999-11-04
ATE178491T1 (de)	1999-04-15
AU1268797A (en)	1997-03-20
AU675946B2 (en)	1997-02-27
CA2099541A1 (en)	1994-01-07
CN1065438C (zh)	2001-05-09
EP0578083B1 (en)	1999-04-07
JP3803392B2 (ja)	2006-08-02
DK0578083T3 (da)	1999-10-18
NO932439D0 (no)	1993-07-05
CZ283744B6 (cs)	1998-06-17
JPH06293659A (ja)	1994-10-21
DE69324305D1 (de)	1999-05-12
HUT66348A (en)	1994-11-28
CN1084408A (zh)	1994-03-30
JP4192114B2 (ja)	2008-12-03

Publication	Publication Date	Title
NO307985B1 (no)	2000-07-03	Farmasøytiske preparater samt anvendelse av syklopeptider ved fremstilling av medikamenter
FI955144A0 (fi)	1995-10-27	Päällystetyt farmaseuttiset koostumukset
BR1100329A (pt)	2000-06-13	Composto e formulação farmacêutica
IL106927A0 (en)	1993-12-28	Sulfonamide derivatives and pharmaceutical compositions containing the same
IL110743A0 (en)	1994-11-11	Heterocyclic compounds and pharmaceutical compositions containing the same
FI950697A0 (fi)	1995-02-16	IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan
FI944832A (fi)	1995-04-16	Farmaseuttinen koostumus
DE69415163D1 (de)	1999-01-21	ZUZAMMENSETUNG ENTHALTEND 1,1,1,2,3,4,4,5,5,5,-DECAFLUORPENTAN UND n-PROPANOL
DE69801369D1 (de)	2001-09-20	Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
IT8323205A0 (it)	1983-10-07	Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
IL110988A0 (en)	1994-11-28	4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
IT1272804B (it)	1997-06-30	"contenitore di imballaggio"
ITMI932540A0 (it)	1993-12-03	Composizione farmaceutica
NO960529L (no)	1996-08-12	Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåte for fremstilling av disse, og deres anvendelse for fremstilling av farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene
LV10579A (lv)	1995-04-20	Farmaceitiska kompozicija
IT1271417B (it)	1997-05-28	Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
FI954982A0 (fi)	1995-10-19	Uusia naftyridiinijohdannaisia, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisia koostumuksia käytettäväksi erityisesti solujen lisääntymistä estävinä lääkkeinä
NO965370L (no)	1997-06-16	Substituerte kromanylsulfonyl(tio)ureaer, fremgangsmåter til deres fremstilling, deres anvendelse i farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene
ITMI931806A0 (it)	1993-08-06	Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica , loro uso e composizioni farmaceutiche che li contengono
ITRM920045A0 (it)	1992-01-21	Composizioni farmaceutiche ad attivita' anti-aging.
ITRM920760A0 (it)	1992-10-20	Derivati amminoacilici e oligopeptidici dell'ipoxantina b-sostituita dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono.
ITRM920043A0 (it)	1992-01-21	Composizioni farmaceutiche ad attivita' anti-aging.
ITRM920044A1 (it)	1993-07-21	Composizioni farmaceutiche ad attivita' anti-aging.
ITMI930181A1 (it)	1994-08-04	Composizione farmaceutica contenente n-acetil-cisteina
IT8820026A0 (it)	1988-03-30	Composizioni farmaceutiche adattivita' antineoplastica.

Legal Events

Date	Code	Title	Description
2013-08-19	MK1K	Patent expired